OHSU spinout gets $4.3M in grants for cancer research
PDX Pharmaceuticals, an Oregon Health& Science startup, was awarded two grants totaling $4.3 million from the National Cancer Institute.
The awards were given to the biotech company to advance two therapeutic candidates, which are immuno-nanotherapeutics for advanced cancers, said Wassana Yantasee, president and CEO of PDX Pharmaceuticals and a professor of biomedical engineering at OHSU.
Yantasee founded the company out of the OH SU Department of Biomedical Engineering. PDX Pharma has received…
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Elizabeth Hayes Source Type: news
More News: Biomedical Engineering | Biotechnology | Cancer | Cancer & Oncology | Grants | Health Management | Nanotechnology | Pharmaceuticals | Science